Marksans Pharma’s US Subsidiary Clears USFDA Hurdle: Boosts Global Expansion Plans

Unknown Apr 02, 2026 750 Views

Marksans Pharma Ltd. has announced a significant regulatory milestone as its wholly owned US subsidiary, Time-Cap Laboratories Inc., received the Establishment Inspection Report (EIR) from the US Food and Drug Administration (USFDA) for its manufacturing facility in Farmingdale, New York. The EIR...